Express Scripts CEO addresses drug pricing ‘misinformation’
[...] Typically, after dispensing drugs to patients, a drug manufacturer will write Express Scripts a rebate check.
That timing can expose some patients, especially those with high deductibles, to the full cost of a drug, said Rachel Sachs, an associate professor of law at Washington University. She focuses on health law and food and drug regulation.
PBMs serve a function, Sachs said, but they are partly to blame for high drug costs. Ultimately, she said, there’s not a lot of transparency in how the rebates are passed through to patients. [...]health care finance health law policy insurance pharmaceuticals public health rachel sachs regulation